NCT02999854: Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
- State
- Stopped early
- Phase
- Phase 3
- People
- 63 taking part
- Started
- 29 Nov 2017
- Primary completion
- 9 Nov 2021
- Arms
- ATIR101
- Results
- Posted on the registry
- 21 Dec 2016: Trial registered
- 29 Nov 2017: Trial started
- 17 Dec 2021: Trial terminated
- 24 May 2022: Trial results posted